Discontinuation report RAN-NABILONE
| Report ID | 16598 |
| Drug Identification Number | 02358085 |
| Brand name | RAN-NABILONE |
| Common or Proper name | RAN-NABILONE |
| Company Name | RANBAXY PHARMACEUTICALS CANADA INC. |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | NABILONE |
| Strength(s) | 0.5MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | A04AD |
| ATC description | ANTIEMETICS AND ANTINAUSEANTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2017-07-12 |
| Actual discontinuation date | 2017-07-12 |
| Remaining supply date | 2017-07-12 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2017-07-21 | French | Compare |
| v1 | 2017-07-21 | English | Compare |
Showing 1 to 2 of 2